Elevance Health, Inc.
ELV
$376.63
$13.893.83%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -11.39% | -5.32% | -13.79% | -19.89% | -5.24% |
| Total Depreciation and Amortization | 3.28% | 12.75% | 9.54% | -10.23% | -24.54% |
| Total Amortization of Deferred Charges | 9.40% | 9.40% | 7.15% | 7.15% | 7.15% |
| Total Other Non-Cash Items | -3,127.27% | 133.12% | 74.36% | -58.59% | -99.15% |
| Change in Net Operating Assets | 146.42% | -90.63% | 54.25% | 89.01% | 54.89% |
| Cash from Operations | 56.90% | -26.14% | 130.50% | 212.24% | 35.77% |
| Capital Expenditure | 1.53% | 11.15% | 9.13% | 10.43% | 7.93% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 102.42% | 101.83% | -228.21% | -254.24% | -256.38% |
| Divestitures | -- | -- | -109.02% | -109.02% | -- |
| Other Investing Activities | -216.20% | -159.07% | 152.68% | 172.74% | 172.85% |
| Cash from Investing | -12.16% | 73.99% | 24.40% | 45.85% | 41.38% |
| Total Debt Issued | -11.90% | -22.43% | 194.31% | 90.86% | 360.60% |
| Total Debt Repaid | -38.97% | -54.80% | -771.53% | -1,749.72% | -656.81% |
| Issuance of Common Stock | -35.37% | -63.35% | -84.08% | -61.84% | -28.64% |
| Repurchase of Common Stock | 16.50% | 12.30% | -87.52% | -25.34% | -22.97% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.26% | -1.39% | -2.97% | -4.89% | -6.47% |
| Other Financing Activities | 306.25% | 1,000.00% | -72.73% | -270.00% | -277.78% |
| Cash from Financing | -213.37% | -245.68% | 7.06% | -150.58% | 73.15% |
| Foreign Exchange rate Adjustments | -200.00% | 16.67% | -333.33% | 112.50% | -150.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -130.00% | -114.29% | -- |
| Net Change in Cash | 69.31% | -31.73% | 127.74% | 159.04% | 132.53% |